
Claudio Helmle, Jörg von Manger-Koenig, and Nicolas Mosimann jointly lead the team at Kellerhals Carrard, which is recommended for its expertise in SPC issues and pricing matters. Bern’s Helmle is particularly active across the biotech and pharma industries, often advising on reimbursement and authorisation matters, while von Manger-Koenig utilises his longstanding experience to advise on corporate issues within the sector. Thomas Eichenberger is noted for his vast knowledge of the rules surrounding the advertising and authorisation of medicinal products. In Basel, Mosimann is well-versed in M&A, R&D, and licence agreement work, often representing start-ups. Promoted to partner in January 2024, Virginie Rodieux is a key name for tech transfer and R&D contracts, and works out of the Lausanne office.
Testimonials
Collated independently by Legal 500 research team.
‘Highly reactive team with deep experience in the life sciences as well as general legal support for small and growing tech companies. They are familiar with licensing deals, capital increases, convertible debt, corporate restructuring, and the entire range of legal services that a start-up and growing life science and technology company require.’
‘Always friendly, reactive, knowledgeable, and understand what their clients are looking for across the spectrum of activities in the life sciences that requires legal support. You can rely on them in both high stakes negotiations as well as in routine legal work.’
‘In addition to their expertise, they are very responsive - a must working with startups. ’
‘The healthcare and life science practice at Kellerhals Carrard is very knowledgeable and provides useful and practical legal advice in a very timely manner.’
‘What definitely stands out for me is Thomas Eichenberger's deep knowledge and expertise in Swiss healthcare law. He is a great legal support and partner.’
‘Extremely quick and competent feedback from the lawyers (in particular Claudio Helmle). Pragmatic and practical knowledge, managing to find out-of-the-box solutions. Feels like they are part of the team, also in terms of team spirit and ways of working.’
‘Claudio Helmle has been an outstanding partner. Compared to other law firms, his engagement, his sense of team work and his excellent quality of work (knowledge, pragmatic results, creative thinking, reactivity) make him an important part of our team.’
‘I have worked with Virginie Rodieux over the past few years on difficult questions. She is very knowledgeable when it comes to the Swiss HRA, but is also able to provide valuable insight on intellectual property. She is able to explain the intricacies of the law in a manner that is understandable for those with no expertise in the area.’
Key clients
- Actelion Pharmaceuticals
- ALK-Abelló
- Bayer
- Biokema
- Cellestia
- Chemspeed Technologies AG
- Eli Lilly
- Entrydell SA
- Fondation EuroVacc
- Fondation Health Sciences e-Training (HSeT)
- Gebro Pharma AG
- Gene Predictis SA
- Gilead Sciences Switzerland Sàrl
- Interpharma
- Kantonsspital St. Gallen
- KetoSwiss AG
- KPT Versicherungen
- Medtronic
- Moderna
- MoonLake Immunotherapeutics AG
- Neurim Pharmaceuticals
- Pharmaledger Association
- Roche
- Takeda
- Vifor Pharma AG
- Ypsomed Holding AG
- Zuger Kantonsspital
Work highlights
- Representing Gilead in a proceeding regarding a matter related to the Freedom of Information Act, which is highly important for Gilead as a disclosure of the net price could lead to an impact on the pricing in foreign countries.
- Advised GETEC Switzerland as it became the new owner and operator of the properties and infrastructure facilities of the Life-Science-ParkRhine Valley and took over employees working in these areas from the previous owner, Novartis.
- Representing Novartis in its appeal against a decision made by the Federal Office of Public Health, which aims to have one of Novartis' key products included on the specialty list, which would make it eligible for reimbursement by social health insurance.
Lawyers

Practice head
The lawyer(s) leading their teams.
Claudio Helmle, Jörg von Manger-Koenig, Nicolas Mosimann